Diagnostic mode and tumor stage of breast cancers in the setting of opportunistic screening;Diagnoseform und tumorstadien von mammakarzinomen unter bedingungen des opportunistischen screenings

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 178, Issue 2, 2006, Pages 221-226

  Graf, Oswald ^a   Obermayer, M ^b   Scheurecker, A ^c   Hopf, C ^a   Kramer, J ^c   Fruhwald F ^b  

^a Institut für Radiologie Dr Graf   (Austria)

^b Institute Fruehwald St Poelten   (Austria)

^c Institut am Schillerpark   (Austria)

Author keywords

Breast; Breast cancer; Breast cancer screening; Breast radiography; Mammography

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRIA; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 32544439547     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858760     Document Type: Article

References (38)

1. Tabar L, Dean PB, Kaufman CS et al. A new era in the diagnosis of breast cancer. Surg Oncol Clin North Am 2000; 2: 233-277
2. Tabar L, Vitak B, Tony HH et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001; 91: 1724-1731
3. Broeders MJ, Verbeek AL, Straatman H et al. Repeated mammographic screening reduces breast cancer mortality along the continuum of age. J Med Screen 2002; 9: 163-167
4. Alexander FE, Anderson TJ, Brown HK et al. 14 years of follow-up from the Edinburgh randomised trial of breast cancer screening. Lancet 1999; 353: 1903-1908
5. Frisell J, Lidbrink E, Hellstrom L et al. Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997; 45: 263-270
6. Fracheboud J, de Koning HJ, Boer R et al. Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast 2001; 10: 12-14
7. Vutuc C, Haidinger G, Waldhör T. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria. Wien Klin Wochenschr 1998; 114: 485-490
8. Österreichische Röntgengesellschaft, Qualitätszertifikat - Mammadiagnostik. 2004; http://www.oerg.at
9. Pfarl G, Helbich TH. Breast Imaging Reporting and Data System (BI-RADSTM) - Deutsche Version. Fortschr Röntgenstr 2002; 174: 921-926
10. Scott-Conner CE, Christie DW. Cancer staging using the American Joint Committee on Cancer TNM System. J Am Coll Surg 1995; 181: 182-188
11. Perry N, Broeders M, de Wolf C et al. European guidelines for quality assurance in mammography screening. 3rd edition. Luxemburg: European Communities, 2001
12. Cady B, Stone MD, Schuler JG et al. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131: 301-308
13. Vutuc C, Waldhör T, Klimont J et al. Survival of women with breast cancer in Austria by age, stage and period of diagnosis. Wien Klin Wochenschr 2002; 114: 438-442
14. Vutuc C, Waldhör T, Haidinger G. Cancer mortality in Austria: 1970-2002. Wien Klin Wochenschr 2004; 166: 669-675
15. Boyle P, dÓnofrio A, Maisonneuve P et al. Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol 2003; 14: 1312-1325
16. European Health For All Database (HFA-DB). World Health Organisation (WHO) Regional Office For Europe. Updated June 2005; http://data.euro.who.int/ hfadb/
17. Jakesz R, Samonigg H, Gnant M et al. Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colon Cancer Study Group. Ann Surg 2003; 237: 556-564
18. Bulliard JL, de Landtsheer JP, Levi F. Profile of women non attending in the Swiss mammography screening pilot programme. Breast 2004; 13: 284-289
19. Miller AB, To T, Baines CJ et al. Canadian National Breast Screening Study: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2001; 93: 396-397
20. Joensuu H, Lehtimaki T, Holli TK et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004; 292: 1064-1073
21. Fracheboud J, de Koning HJ, Beemsterboer PM et al. Interval cancers in the Dutch breast cancer screening programe. Br J Cancer 1999; 81: 912-917
22. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 1992; 184: 613-617
23. Destounis SV, DiNitto P, Logan-Young W et al. Can computer aided detection with double reading of screening mammograms help decrease the false negative rate? Initial experience. Radiology 2004; 232: 578-584
24. Funovics M, Schamp S, Helbich TH et al. Evaluierung eines computerassistierten Diagnosesystems in der Erkennung des Mammakarzinoms. Fortschr Röntgenstr 2001; 173: 218-223
25. Obenauer S, Sohns C, Werner C et al. Retrospektive Analyse eines computerassistierten Detektions-Systems (CAD) in der digitalen Vollfeldmammographie in Abhängigkeit von der Histologie. Fortschr Röntgenstr 2005; 177: 1103-1109
26. Grunert JH, Khalifa R, Gmelin E. Computerassistierte Segmentierung und Formanalyse von 2975 Mikroverkalkungen mit Hilfe der 7fachen Vergrößerungspräparatradiographie. Fortschr Röntgenstr 2004; 176: 1759-1765
27. Schulz-Wendtlandt R, Hermann KP, Lell M et al. Phantomstudie zur Detektion simulierter Läsionen an fünf verschiedenen digitalen und einem konventionellen Mammographiesystem. Fortschr Röntgenstr 2004; 176: 1127-1132
28. Schulz-Wendtlandt R, Lell M, Wenkel E et al. Digitale Mammographie mit hochauflösenden Speicherfolien (CR) versus digitaler Vollfeldmammographie (CCD) (DR): Mikrokalzifikationen und Heidbefunde - eine retrospektiv klinisch-histologische Analyse. Fortschr Röntgenstr 2005; 177: 67-71
29. Diekmann F, Diekmann S, Beljavskaja M et al. Präoperative MRT der Brust beim invasiv-lobulären Karzinom im Vergleich zum invasivduktalen Karzinom. Fortschr Röntgenstr 2004; 176: 544-549
30. Vomweg TW, Teifke A, Kauczor HU et al. Selbstorganisierende neuronale Netze zur automatischen Detektion und Klassifikation von Kontrast(mittel)- verstärkten Läsionen in der dynamischen MR-Mammographie. Fortschr Röntgenstr 2005; 177: 703-713
31. Birrenbach S, Miller S, Stern W et al. Klinischer Stellenwert bildgebender Verfahren im ersten Jahr nach brusterhaltender Therapie des Mammakarzinoms. Fortschr Röntgenstr 2004; 176: 1423-1430
32. White E, Miglioretti DL, Yankaskas BC et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004; 96: 1832-1839
33. Feig SA, Kopans DB, Sickles Ea et al. Rationale for annual screening mammography for woman ages 40-49 years. Breast Dis 1998; 10: 13-21
34. Bundesministerium für Gesundheit und Frauen. Mammographiescreening in Österreich. In: ÖBIG (Hrsg). Wien, 2004
35. Graf O, Helbich TH, Fuchsjäger MH et al. Sonographische Verlaufskontrollen bei palpablen soliden, wahrscheinlich gutartigen Brustläsionen (Bl-RADSTM Kategorie 3). Fortschr Röntgenstr 2004; 176: 1251-1256
36. Graf O, Helbich TH, Fuchsjäger MH et al. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted? Radiology 2004; 233: 850-856
37. Pacher B, Tscherney R, Litmann-Rowenta B et al. Konsensuelles Zweitbefunden in der Praxis. Fortschr Röntgenstr 2004; 176: 1766-1769
38. Vacek PM, Geller BM, Weaver DL et al. Increased mammography use and its impact on earlier breast cancer detection in Vermont 1975-1999. Cancer 2002; 94: 2160-2168